Annual D&A:
$2.06M+$105.00K(+5.37%)Summary
- As of today, JANX annual D&A is $2.06 million, with the most recent change of +$105.00 thousand (+5.37%) on December 31, 2024.
- During the last 3 years, JANX annual D&A has risen by +$1.95 million (+1723.01%).
- JANX annual D&A is now at all-time high.
Performance
JANX Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$501.00K-$40.00K(-7.39%)Summary
- As of today, JANX quarterly D&A is $501.00 thousand, with the most recent change of -$40.00 thousand (-7.39%) on September 30, 2025.
- Over the past year, JANX quarterly D&A has dropped by -$9000.00 (-1.76%).
- JANX quarterly D&A is now -7.39% below its all-time high of $541.00 thousand, reached on June 30, 2025.
Performance
JANX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.07M-$9000.00(-0.43%)Summary
- As of today, JANX TTM D&A is $2.07 million, with the most recent change of -$9000.00 (-0.43%) on September 30, 2025.
- Over the past year, JANX TTM D&A has dropped by -$6000.00 (-0.29%).
- JANX TTM D&A is now -0.43% below its all-time high of $2.08 million, reached on June 30, 2025.
Performance
JANX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
JANX Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +5.4% | -1.8% | -0.3% |
| 3Y3 Years | +1723.0% | +101.2% | +312.9% |
| 5Y5 Years | +10000.0% | +10000.0% | +10000.0% |
JANX Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +1723.0% | -7.4% | +101.2% | -0.4% | +312.9% |
| 5Y | 5-Year | at high | >+9999.0% | -7.4% | >+9999.0% | -0.4% | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -7.4% | >+9999.0% | -0.4% | >+9999.0% |
JANX Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $501.00K(-7.4%) | $2.07M(-0.4%) |
| Jun 2025 | - | $541.00K(+4.2%) | $2.08M(+1.7%) |
| Mar 2025 | - | $519.00K(+1.4%) | $2.05M(-0.6%) |
| Dec 2024 | $2.06M(+5.4%) | $512.00K(+0.4%) | $2.06M(-0.9%) |
| Sep 2024 | - | $510.00K(+0.8%) | $2.08M(+0.5%) |
| Jun 2024 | - | $506.00K(-4.9%) | $2.07M(+1.7%) |
| Mar 2024 | - | $532.00K(+0.2%) | $2.03M(+4.0%) |
| Dec 2023 | $1.96M(+132.5%) | $531.00K(+6.2%) | $1.96M(+7.0%) |
| Sep 2023 | - | $500.00K(+6.2%) | $1.83M(+15.9%) |
| Jun 2023 | - | $471.00K(+4.0%) | $1.58M(+29.9%) |
| Mar 2023 | - | $453.00K(+12.4%) | $1.21M(+44.2%) |
| Dec 2022 | $841.00K | $403.00K(+61.8%) | $841.00K(+67.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $249.00K(+130.6%) | $502.00K(+79.3%) |
| Jun 2022 | - | $108.00K(+33.3%) | $280.00K(+51.4%) |
| Mar 2022 | - | $81.00K(+26.6%) | $185.00K(+63.7%) |
| Dec 2021 | $113.00K(+769.2%) | $64.00K(+137.0%) | $113.00K(+130.6%) |
| Sep 2021 | - | $27.00K(+107.7%) | $49.00K(+113.0%) |
| Jun 2021 | - | $13.00K(+44.4%) | $23.00K(+109.1%) |
| Mar 2021 | - | $9000.00(+800.0%) | $11.00K(+175.0%) |
| Dec 2020 | $13.00K(+116.7%) | - | - |
| Sep 2020 | - | $1000.00(0.0%) | $4000.00(+33.3%) |
| Jun 2020 | - | $1000.00(-50.0%) | $3000.00(+50.0%) |
| Mar 2020 | - | $2000.00 | $2000.00 |
| Dec 2019 | $6000.00 | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual D&A year-on-year change?
- What is Janux Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Janux Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM D&A year-on-year change?
What is Janux Therapeutics, Inc. annual D&A?
The current annual D&A of JANX is $2.06M
What is the all-time high annual D&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual D&A is $2.06M
What is Janux Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, JANX annual D&A has changed by +$105.00K (+5.37%)
What is Janux Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of JANX is $501.00K
What is the all-time high quarterly D&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly D&A is $541.00K
What is Janux Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, JANX quarterly D&A has changed by -$9000.00 (-1.76%)
What is Janux Therapeutics, Inc. TTM D&A?
The current TTM D&A of JANX is $2.07M
What is the all-time high TTM D&A for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM D&A is $2.08M
What is Janux Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, JANX TTM D&A has changed by -$6000.00 (-0.29%)